Clinical Trial Update: A Study of NUC-3373 in Combination With Other Agents in Patients With Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update for NUC-3373 in combination with other agents in colorectal cancer; the study was terminated and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Adenocarcinoma
• Colorectal Cancer
• Colorectal Neoplasms

Drugs mentioned

• NUC-3373

Snippet

Sponsor: NuCana plc | Conditions: Colorectal Cancer, Colorectal Neoplasms | Phase 2 | Status: TERMINATED | Results posted: 2025-09-12